| 0 (0%) | 11-07 09:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.1 | 1-year : | 10.69 |
| Resists | First : | 6.94 | Second : | 9.15 |
| Pivot price | 5  |
|||
| Supports | First : | 3.34 | Second : | 2.78 |
| MAs | MA(5) : | 3.8 |
MA(20) : | 5.32 |
| MA(100) : | 14.79 |
MA(250) : | 18.55 |
|
| MACD | MACD : | -1.7  |
Signal : | -1.8 |
| %K %D | K(14,3) : | 8.8 |
D(3) : | 6.1 |
| RSI | RSI(14): 30.2 |
|||
| 52-week | High : | 41.25 | Low : | 3.34 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ FGF ] has closed above bottom band by 16.2%. Bollinger Bands are 63.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.94 - 3.96 | 3.96 - 3.97 |
| Low: | 3.52 - 3.54 | 3.54 - 3.56 |
| Close: | 3.7 - 3.73 | 3.73 - 3.76 |
FG Financial Group, Inc. operates as a reinsurance and investment management holding company in the United States. The company offers specialty property and casualty reinsurance products and services. It also operates a special purpose acquisition company platform (SPAC) that provides various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. The company was formerly known as 1347 Property Insurance Holdings, Inc. and changed its name to FG Financial Group, Inc. in December 2020. The company was incorporated in 2012 and is based in St. Petersburg, Florida.
Tue, 04 Nov 2025
WACKER launches FGF-2 Food growth factor for lab-grown meat - Nutraceutical Business Review
Wed, 27 Aug 2025
A Journey of Growth and Impact at FGF: An Interview with Janvi Thaker - FGF Brands
Fri, 22 Aug 2025
Regulation of feather length: FGF/IGF signaling and NOTCH/YAP modulation of progenitor cell topology - Science | AAAS
Tue, 19 Aug 2025
China's RemeGen sells Asia rights to VEGF/FGF eye drug in $180M deal - Fierce Biotech
Tue, 05 Aug 2025
FGF receptor modulates planar cell polarity in the neuroectoderm via Vangl2 tyrosine phosphorylation - Nature
Fri, 01 Aug 2025
Fundamental Global Shareholders to Get $10 Cash Dividend Plus $30+ in Trust Assets - See Distribution Timeline - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Insurance - Diversified
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 14.6 (%) |
| Held by Institutions | 35.4 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 4 (K) |
| EPS | -13.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 36.56 |
| Profit Margin | 23 % |
| Operating Margin | 34.5 % |
| Return on Assets (ttm) | -10.2 % |
| Return on Equity (ttm) | -23.9 % |
| Qtrly Rev. Growth | 94.5 % |
| Gross Profit (p.s.) | -3.11 |
| Sales Per Share | 16.29 |
| EBITDA (p.s.) | -11.61 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | 9 (M) |
| PE Ratio | -0.29 |
| PEG Ratio | 0 |
| Price to Book value | 0.1 |
| Price to Sales | 0.22 |
| Price to Cash Flow | -0.94 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|